Dense deposit disease in korean children: A multicenter clinicopathologic study

Journal of Korean Medical Science

Volumn 27, Issue 10, 2012, Pages 1215-1221

  Park, Se Jin ^a   Kim, Yong Jin ^b   Ha, Tae Sun ^c   Lim, Beom Jin ^d   Jeong, Hyeon Joo ^d   Park, Yong Hoon ^b   Lee, Dae Yeol ^e   Kim, Pyung Kil ^f   Kim, Kyo Sun ^g   Chung, Woo Yeong ^h   Shin, Jae Il ⁱ  

^a Ajou University Medical CentSuwon   (South Korea)

^b Yeungnam University College of Medicine   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e Chonbuk National University Medical School   (South Korea)

^f Kwandong University College of Medicine   (South Korea)

^g Konkuk University School of Medicine   (South Korea)

^h Inje University College of Medicine   (South Korea)

ⁱ Yonsei University College of Medicine   (South Korea)

Author keywords

Dense deposit disease; Electron dense deposit; Membranoproliferative glomerulonephritis

Indexed keywords

CREATININE; SERUM ALBUMIN;

ADOLESCENT; ARTICLE; ASIAN; BLOOD; CHILD; COMPARATIVE STUDY; EDEMA; ELECTRON MICROSCOPY; FEMALE; HEMATURIA; HUMAN; INFANT; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MULTICENTER STUDY; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; PROTEINURIA; SOUTH KOREA; UNITED STATES;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; CREATININE; EDEMA; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HEMATURIA; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROSCOPY, ELECTRON; PROTEINURIA; REPUBLIC OF KOREA; SERUM ALBUMIN; UNITED STATES;

EID: 84872572817     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2012.27.10.1215     Document Type: Article

References (30)

1. Sethi S, Sukov WR, Zhang Y, Fervenza FC, Lager DJ, Miller DV, Cornell LD, Krishnan SG, Smith RJ. Dense deposit disease associated with monoclonal gammopathy of undetermined significance. Am J Kidney Dis 2010; 56: 977-82.
2. Cameron JS, Turner DR, Heaton J, Williams DG, Ogg CS, Chantler C, Haycock GB, Hicks J. Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med 1983; 74: 175-92.
3. Swainson CP, Robson JS, Thomson D, MacDonald MK. Mesangiocapillary glomerulonephritis: a long-term study of 40 cases. J Pathol 1983; 141: 449-68.
4. Galle P. A description of a unique lesion of the glomerular basement membranes seen as a hyaline substance with the electron microscope [in Frence] lé sion singulière des membranes basales du rein et de la substance hyaline [thesis]. Paris: Medical School, University of Paris; 1962.
5. Nasr SH, Valeri AM, Appel GB, Sherwinter J, Stokes MB, Said SM, Markowitz GS, D'Agati VD. Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients. Clin J Am Soc Nephrol 2009; 4: 22-32.
6. Lu DF, Moon M, Lanning LD, McCarthy AM, Smith RJ. Clinical features and outcomes of 98 children and adults with dense deposit disease. Pediatr Nephrol 2012; 27: 773-81.
7. Alchi B, Jayne D. Membranoproliferative glomerulonephritis. Pediatr Nephrol 2010; 25: 1409-18.
8. Sung JH, Kang MJ, Hwang EA, Han SY, Park SB, Kim HC, Park KK. Two cases of type II membranoproliferative glomerulonephritis. Korean J Nephrol 2004; 23: 335-40.
9. Kim HJ, Kwak BO, Bae JU, Kim KS, Lim SD. A case of type II membranoproliferative glomerulonephritis detected by school urinary screening tests. J Korean Soc Pediatr Nephrol 2010; 14: 79-83.
10. Lee SJ, Moon JH, Kang MS, Song MS, Chung WY. A case of membranoproliferative glomerulonephritis type II (Dense-Deposit Disease). J Korean Soc Pediatr Nephrol 2003; 7: 204-10.
11. Kwon HS, Oh SJ, Lee YM, Kim JH, Kim PK, Kang HY, Jeong HJ, Choi IJ. A case of membranoproliferative glomerulonephritis type II: Dense Deposit Disease, DDD. J Korean Soc Pediatr Nephrol 2001; 5: 188-95.
12. Kim MS, Hwang PH, Kang MJ, Lee DY. A case of regression of atypical dense deposit disease without C3 deposition in a child. Korean J Pediatr 2010; 53: 766-9.
13. Kim MJ, Lim BJ, Shin JI, Lee JS, Lee YH, Joh K, Kim PK, Jeong HJ. Development of IgA nephropathy after clinical remission of Dense Deposit Disease. Korean J Nephrol 2010; 29: 125-30.
14. Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, Kirschfink M, Lambris JD, Lanning L, Lutz HU, Meri S, et al. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol 2005; 16: 1392-403.
15. Bennett WM, Fassett RG, Walker RG, Fairley KF, d'Apice AJ, Kincaid-Smith P. Mesangiocapillary glomerulonephritis type II (dense-deposit disease): clinical features of progressive disease. Am J Kidney Dis 1989; 13: 469-76.
16. Schwertz R, de Jong R, Gretz N, Kirschfink M, Anders D, Scharer K. Outcome of idiopathic membranoproliferative glomerulonephritis in children. Arbeitsgemeinschaft Padiatrische Nephrologie. Acta Paediatr 1996; 85: 308-12.
17. Walker PD. Dense deposit disease: new insights. Curr Opin Nephrol Hypertens 2007; 16: 204-12.
18. Cameron JS, Turner DR, Heaton J, Williams DG, Ogg CS, Chantler C, Haycock GB, Hicks J. Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med 1983; 74: 175-92.
19. Nevins TE. Lectin binding in membranoproliferative glomerulonephritis. Evidence for N-acetylglucosamine in dense intramembranous deposits. Am J Pathol 1985; 118: 325-30.
20. Sibley RK, Kim Y. Dense intramembranous deposit disease: new pathologic features. Kidney Int 1984; 25: 660-70.
21. Swainson CP, Robson JS, Thomson D, MacDonald MK. Mesangiocapillary glomerulonephritis: a long-term study of 40 cases. J Pathol 1983; 141: 449-68.
22. Sethi S, Nester CM, Smith RJ. Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney Int 2012; 81: 434-41.
23. Walker PD, Ferrario F, Joh K, Bonsib SM. Dense deposit disease is not a membranoproliferative glomerulonephritis. Mod Pathol 2007; 20: 605-16.
24. Licht C, Heinen S, Józsi M, Löschmann I, Saunders RE, Perkins SJ, Waldherr R, Skerka C, Kirschfink M, Hoppe B, et al. Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). Kidney Int 2006; 70: 42-50.
25. Kurtz KA, Schlueter AJ. Management of membranoproliferative glomerulonephritis type II with plasmapheresis. J Clin Apher 2002; 17: 135-7.
26. Jansen JH, Hoøgåsen K, Harboe M, Hovig T. In situ complement activation in porcine membranoproliferative glomerulonephritis type II. Kidney Int 1998; 53: 331-49.
27. Bayary J, Dasgupta S, Misra N, Ephrem A, Duong Van Huyen JP, Delignat S, Hassan G, Caligiuri G, Nicoletti A, Lacroix-Desmazes S, et al. Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms. Int Immunopharmacol 2006; 6: 528-34.
28. Lutz HU, Stammler P, Bianchi V, Trüeb RM, Hunziker T, Burger R, Jelezarova E, Späth PJ. Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level. Blood 2004; 103: 465-72.
29. Hillmen P, Young NS, Schubert J, Brodsky RA, Socié G, Muus P, Röth A, Szer J, Elebute MO, Nakamura R, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006; 355: 1233-43.
30. Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, Cullen MJ, Richards SJ, Rollins SA, Mojcik CF, et al. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 2004; 350: 552-9.